Runda Medical provides CNY 239m in subsidiary guarantees

Shanghai Runda Medical Technology (SSE:603108) announced it provided guarantees totaling CNY 23.905 million for several subsidiaries in April 2025. The beneficiaries include wholly-owned subsidiaries Hangzhou Runda, Huizhong Biology, and Harbin Runda, as well as holding subsidiaries Hefei Runda, Yunnan Kangtai, Wuhan Shangjian, Hefei Sanli, and Runda Rongjia. As of the announcement date, the outstanding balance of guarantees for these entities reached CNY 230.44556 million, representing 72.71% of the company's latest audited net assets. Notably, subsidiaries Runda Rongjia and Hangzhou Runda, have an asset-liability ratio exceeding 70%. The company mitigates risk through counter-guarantees, with minority shareholders of holding subsidiaries pledging their equity.